Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from British American Tobacco ( (GB:BATS) ).
British American Tobacco has executed a share buyback, purchasing 103,500 of its ordinary shares from Banco Santander as part of its ongoing buyback program. The company plans to cancel these shares, which will adjust the total number of shares in issue and those held in treasury. This move is part of BAT’s strategy to manage its capital structure and potentially enhance shareholder value.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £4586.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
Spark’s Take on GB:BATS Stock
According to Spark, TipRanks’ AI Analyst, GB:BATS is a Neutral.
British American Tobacco’s overall stock score is driven by strong technical momentum and strategic corporate actions such as share buybacks. While financial performance shows robust cash flow, concerns about earnings stability and a high P/E ratio temper the score. The earnings call provided a mixed outlook, with growth in new categories but challenges in key markets. The attractive dividend yield and strategic deleveraging efforts further support the stock’s appeal.
To see Spark’s full report on GB:BATS stock, click here.
More about British American Tobacco
British American Tobacco p.l.c. is a leading company in the tobacco industry, known for its production and sale of cigarettes, tobacco, and nicotine products. The company operates globally, focusing on delivering high-quality products while navigating regulatory challenges and shifting consumer preferences towards reduced-risk products.
Average Trading Volume: 4,824,971
Technical Sentiment Signal: Buy
Current Market Cap: £93.04B
For a thorough assessment of BATS stock, go to TipRanks’ Stock Analysis page.

